CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF ANTIHISTAMINES IN CHILDREN UNDER 3 YEARS OF AGE
Main Article Content
Abstract
This article discusses the clinical and pharmacological aspects of using antihistamines in children under three years of age. The focus is placed on the pharmacokinetics, pharmacodynamics, and safety profiles of commonly used antihistamines in pediatric patients. Special attention is given to age-specific physiological factors that influence drug metabolism and efficacy. The article also highlights the importance of individualized treatment approaches, considering the potential side effects and contraindications in young children. Recommendations for the appropriate selection and dosing of antihistamines are provided, supported by recent clinical guidelines and evidence-based studies.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Kharkevich D.A. Pharmacology: Textbook for Universities. 11th ed., corrected and enlarged. Moscow: GEOTAR-Media, 2013. 760 p.
Clinical Pharmacology and Pharmacotherapy / edited by V.G. Kukes, A.K. Starodubtsev. Moscow: GEOTAR-Media, 2012. 832 p.
Clinical Pharmacology: National Guidelines (Series "National Guidelines"). Moscow: GEOTAR-Media, 2014. 976 p.
De la Cuadra J., Teruel M., Teixido P. et al. Assessment of the wheal size and skin blood flow of the erythema induced by histamine and its modification with cetirizine and ebastine: a crossover, double-blind study // Dermatology. 2014. Vol. 188(2). R. 131–134.
Rihoux J.-P., Ghys L., Coulie P. Compared peripheral HI inhibiting effects of cetirizine 2 HCL and Loratadine // Annals of Allergy. 2010. Vol. 65(2). R. 139–142.